BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brigstock DR. Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. Cells 2021;10:1596. [PMID: 34202136 DOI: 10.3390/cells10071596] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Teng L, Maqsood M, Zhu M, Zhou Y, Kang M, Zhou J, Chen J. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Accelerate Diabetic Wound Healing via Promoting M2 Macrophage Polarization, Angiogenesis, and Collagen Deposition. IJMS 2022;23:10421. [DOI: 10.3390/ijms231810421] [Reference Citation Analysis]
2 Li L, Fu H, Liu Y. The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat Rev Nephrol 2022. [PMID: 35788561 DOI: 10.1038/s41581-022-00590-z] [Reference Citation Analysis]
3 Gholaminejad A, Ghaeidamini M, Simal-Gandara J, Roointan A. An Integrative in silico Study to Discover Key Drivers in Pathogenicity of Focal and Segmental Glomerulosclerosis. Kidney Blood Press Res 2022;47:410-22. [PMID: 35306494 DOI: 10.1159/000524133] [Reference Citation Analysis]
4 Avalos PN, Forsthoefel DJ. An Emerging Frontier in Intercellular Communication: Extracellular Vesicles in Regeneration. Front Cell Dev Biol 2022;10:849905. [PMID: 35646926 DOI: 10.3389/fcell.2022.849905] [Reference Citation Analysis]
5 Hirakawa T, Yotsumoto F, Shirasu N, Kiyoshima C, Urushiyama D, Yoshikawa K, Miyata K, Kurakazu M, Koga KA, Aoki M, Nabeshima K, Koga KS, Osuga Y, Komatsu H, Taniguchi F, Harada T, Yasunaga S, Miyamoto S. Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-11891-5] [Reference Citation Analysis]
6 Martín-Taboada M, Corrales P, Medina-Gómez G, Vila-Bedmar R. Tackling the effects of extracellular vesicles in fibrosis. Eur J Cell Biol 2022;101:151221. [PMID: 35405464 DOI: 10.1016/j.ejcb.2022.151221] [Reference Citation Analysis]
7 Yang T, Wang J, Zhao J, Liu Y. Current and prospective applications of exosomal microRNAs in pulmonary fibrosis (Review). Int J Mol Med 2022;49:37. [PMID: 35088880 DOI: 10.3892/ijmm.2022.5092] [Reference Citation Analysis]
8 Salvati A, Poelstra K. Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation. Pharmaceutics 2022;14:217. [DOI: 10.3390/pharmaceutics14010217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nazarie Ignat SR, Gharbia S, Hermenean A, Dinescu S, Costache M. Regenerative Potential of Mesenchymal Stem Cells' (MSCs) Secretome for Liver Fibrosis Therapies. Int J Mol Sci 2021;22:13292. [PMID: 34948088 DOI: 10.3390/ijms222413292] [Reference Citation Analysis]
10 Giacomelli C, Piccarducci R, Marchetti L, Romei C, Martini C. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients. Biochem Pharmacol 2021;193:114812. [PMID: 34687672 DOI: 10.1016/j.bcp.2021.114812] [Reference Citation Analysis]
11 Xue T, Qiu X, Liu H, Gan C, Tan Z, Xie Y, Wang Y, Ye T. Epigenetic regulation in fibrosis progress. Pharmacol Res 2021;173:105910. [PMID: 34562602 DOI: 10.1016/j.phrs.2021.105910] [Reference Citation Analysis]